| Literature DB >> 31190801 |
Xiaowen Hu1, Kandasamy Saravanakumar1, Tieyan Jin2, Myeong-Hyeon Wang1.
Abstract
Background: Biogenic silver nanoparticles (Entities:
Keywords: Talaromyces purpureogenus; antibacterial; anticancer; cell wound healing; mycosynthesis; silver nanoparticles
Mesh:
Substances:
Year: 2019 PMID: 31190801 PMCID: PMC6515543 DOI: 10.2147/IJN.S200817
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1. Synthesis of the Tp-AgNPs using the endophytic fungi extracts and their characterization by UV-visible spectrophotometer (A), FTIR analysis (B), Particle size analysis (C), XRD pattern analysis (D).
Abbreviations: FTIR, Fourier transform infrared spectroscopy; XRD, X-ray diffraction; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles.
Figure 2FETEM image of Tp-AgNPs at <100 nm (A) and 20 nm (B). EDS-based mapping of the Ag (C) and carbon in Tp-AgNPs (D). EDS chromatograph of Tp-AgNPs (E).
Abbreviations: FETEM, field emission transmission electron microscopy; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; EDS, energy-dispersive X-ray spectroscopy; Ag, silver.
Figure 3Cytotoxicity of Tp-AgNPs and AgNO3 in A549 cells (A). Flow cytometry-based analysis of cell death in A549 cells untreated (B) and treated with Tp-AgNPs (C) and analysis of the ROS generation in A549 cells untreated (E) and treated with Tp-AgNPs (D).
Abbreviations: CK, control group; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; AgNO3, silver nitrate; ROS, reactive oxygen species.
Figure 4Antibactrial activity of Tp-AgNPs: Staphylococcus aureus (A), Bcillus cereus (B), Salmonella entrica (C), Pseudomonas aeruginosa (D), and Escherichia coli (E). Ab – vancomycin; different concentrations of Tp-AgNPs solution: 25–100 µg mL−1.
Abbreviations: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; Ab, vancomycin.
Antibacterial activity of silver nanoparticles (AgNPs) synthesized by endophytic fungi
| No. | Name of host plant | Name of endophytic fungi | AgNPs size (nm) | Application | Reference |
|---|---|---|---|---|---|
| 1 | 20–50 | Antibacterial | |||
| 2 | 45.2 | Antifungal | |||
| 3 | 18.7 | Antimicrobial and larvicidal activity | |||
| 4 | 33.52 | Antibacterial | |||
| 5 | 10–15 | Antibacterial | |||
| 6 | – | Antibacterial | |||
| 7 | 41.9 | Antibacterial | |||
| 8 | 16.45 | Antibacterial | |||
| 9 | 10–15 | Antibacterial | |||
| 10 | 5–20 | Antimicrobial | |||
| 11 | 16 | Antibacterial | |||
| 12 | orchids, | KDH5 | 15–25 | Antibacterial | |
| 13 | 10–30 | Antibacterial | |||
| 14 | 65 | Antioxidant | |||
| 15 | 123–195 | Unknown | |||
| 16 | 26 | Antimicrobial | |||
| 17 | 10–50 | Antimicrobial | |||
| 18 | 3.5 | Unknown | |||
| 19 | 25–30 | Antibacterial | |||
| 20 | MGE-201 | 35 | Antifungal | ||
| 21 | <50 | Antibacterial | Present study |
Zone of inhibition of produced by Tp-AgNPs synthesized from endophytic fungi Talaromyces purpureogenus against bacterial pathogens
| Pathogenic bacterial strains | Zone of inhibition (mm) | ||||
|---|---|---|---|---|---|
| Vancomycin (5 μg/mL) | Silver nanoparticles (Tp-AgNPs) | ||||
| 25 μg/mL | 50 μg/mL | 75 μg/mL | 100 μg/mL | ||
| 9 | 6 | 7 | 8 | 9 | |
| 22 | 8 | 9 | 10 | 11 | |
| 20 | 8 | 9 | 9.5 | 11 | |
| 15 | 7.5 | 8 | 10.5 | 13 | |
| 8 | 8 | 8.5 | 9.5 | 11 | |
Abbreviations: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; S.aureus, Staphylococcus ; B.cereus, Bcillus cereus; S.enterica, Salmonella entrica; P.aeruginosa, Pseudomonas aeruginosa;E.coli, Escherichia coli.
Figure 5Wound healing effect of the Tp-AgNPs in NIH3T3 cells at different time intervals.
Abbreviations: CK, control group; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; NIH3T3, Swiss albino mouse embryo tissue.
Cell wound healing efficiency of Tp-AgNPs
| Concentration of Tp-AgNPs (μg/mL) | Wound healing area (cm2) | |||
|---|---|---|---|---|
| 0 hrs | 12 hrs | 24 hrs | 48 hrs | |
| Untreated | 5.244 | 3.8 | 3.79 | 2.356 |
| 1 | 5.434 | 3.487 | 2.888 | 1.976 |
| 5 | 5.776 | 4.18 | 3.42 | 1.824 |
| 10 | 6.156 | 3.42 | 2.546 | 1.436 |
Abbreviation: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles.
Figure 6The growth rate of wound healing effort of the Tp-AgNPs in NIH3T3 cells at different time intervals.
Abbreviations: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; NIH3T3, Swiss albino mouse embryo tissue.